NARG2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 8.57259996323023E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.04319999999436E-05 |
Normal-vs-Stage2 |
7.843700E-02 |
Normal-vs-Stage3 |
1.49369405733069E-12 |
Normal-vs-Stage4 |
1.29469768239687E-11 |
Stage1-vs-Stage2 |
6.376200E-01 |
Stage1-vs-Stage3 |
3.5352000000044E-05 |
Stage1-vs-Stage4 |
1.647740E-04 |
Stage2-vs-Stage3 |
2.562000E-02 |
Stage2-vs-Stage4 |
1.768410E-02 |
Stage3-vs-Stage4 |
6.944200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.38079999656426E-08 |
Normal-vs-AfricanAmerican |
3.97830000054E-07 |
Normal-vs-Asian |
1.984800E-01 |
Caucasian-vs-AfricanAmerican |
3.653400E-01 |
Caucasian-vs-Asian |
4.879600E-01 |
AfricanAmerican-vs-Asian |
2.464000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.04629999611683E-08 |
Normal-vs-Female |
1.52469999958882E-07 |
Male-vs-Female |
8.729200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.198310E-04 |
Normal-vs-Age(41-60Yrs) |
2.76539999999326E-06 |
Normal-vs-Age(61-80Yrs) |
2.10670003664148E-09 |
Normal-vs-Age(81-100Yrs) |
7.8414000004301E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.975000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.952600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.956600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.531000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.100100E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.059780E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.769800E-01 |
Normal-vs-Grade 2 |
4.172000E-04 |
Normal-vs-Grade 3 |
1.58110191605942E-11 |
Normal-vs-Grade 4 |
1.63169477929159E-12 |
Grade 1-vs-Grade 2 |
2.526400E-01 |
Grade 1-vs-Grade 3 |
1.131840E-02 |
Grade 1-vs-Grade 4 |
7.54299999999875E-05 |
Grade 2-vs-Grade 3 |
8.219800E-04 |
Grade 2-vs-Grade 4 |
1.9538999973534E-08 |
Grade 3-vs-Grade 4 |
1.478490E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.180700E-03 |
Normal-vs-ccB subtype |
9.74680000043193E-08 |
ccA subtype-vs-ccB subtype |
4.062700E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.47090000002237E-06 |
Normal-vs-N1 |
1.424480E-04 |
N0-vs-N1 |
1.986610E-01 |
|
|